Welcome to LookChem.com Sign In|Join Free

CAS

  • or

193270-06-3

Post Buying Request

193270-06-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

193270-06-3 Usage

General Description

(S)-2-acetylamino-3-(4-cyano-phenyl)-propionic acid is a chemical compound that falls under the category of non-steroidal anti-inflammatory drugs (NSAIDs). It is commonly used to alleviate pain, reduce inflammation, and lower fevers. The compound works by inhibiting the production of prostaglandins, which are responsible for causing pain and inflammation in the body. It is often prescribed for conditions such as arthritis, menstrual cramps, and acute injuries. However, like all NSAIDs, it may have side effects such as gastrointestinal issues and an increased risk of cardiovascular problems.

Check Digit Verification of cas no

The CAS Registry Mumber 193270-06-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,3,2,7 and 0 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 193270-06:
(8*1)+(7*9)+(6*3)+(5*2)+(4*7)+(3*0)+(2*0)+(1*6)=133
133 % 10 = 3
So 193270-06-3 is a valid CAS Registry Number.

193270-06-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S)-2-acetamido-3-(4-cyanophenyl)propanoic acid

1.2 Other means of identification

Product number -
Other names ACETYL-L-4-CYANOPHENYLALANINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:193270-06-3 SDS

193270-06-3Downstream Products

193270-06-3Relevant articles and documents

Fluorobenzamidrazone thrombin inhibitors: Influence of fluorine on enhancing oral absorption

Lee, Koo,Jung, Won-Hyuk,Sang, Yeul Hwang,Lee, Sung-Hack

, p. 2483 - 2486 (2007/10/03)

LB30057 (1) is a selective and efficacious oral thrombin inhibitor. Fluorine-substitution on the phenylene ring of the benzamidrazone portion in both compound 1 and its derivatives gave, in many cases, enhanced oral absorption in rats while maintaining the intrinsic potency and selectivity. Compound 2 demonstrated a 3-fold increase in absorption.

Thrombus imaging using technetium-99m-labeled high-potency GPIIb/IIIa receptor antagonists. Chemistry and initial biological studies

Pearson, Daniel A.,Lister-James, John,McBride, William J.,Wilson, David M.,Martel, Lawrence J.,Civitello, Edgar R.,Dean, Richard T.

, p. 1372 - 1382 (2007/10/03)

Platelet-specific compounds which are radiolabeled with γ-emitting radionuclides may be particularly useful for the noninvasive in vivo detection of thrombi. The synthesis of peptides which are potent inhibitors of platelet aggregation and which contain a chelator for the radionuclide technetium-99m are described. The target compounds were designed such that stable, oxotechnetium(V) species could be prepared where the site of metal coordination was well defined. A strategy was employed where the pharmacophore -Arg-Gly-Asp-(RGD), or RGD mimetic, was constrained in a ring which was formed by the S-alkylation of a cysteine residue with an N-terminal chloroacetyl group. Binding affinities were enhanced by the replacement of arginine with the arginine mimetics S-(3-aminopropyl)cysteine and 4- amidinophenylalanine. Further enhancements could be obtained by the synthesis of oligomers which contained two or more rings containing receptor binding regions. The increase in binding affinity seen was more than that expected from a simple stoichiometric increase of pharmacophore. The most potent compounds described had IC50s of approximately 0.03 μM for the inhibition of human platelet aggregation. Two of the more potent peptides (P280 and P748) were labeled with technetium-99m and assessed in a canine thrombosis model. The 99mTc complexes of the peptides prepared in this work hold promise as thrombus imaging agents due to their high receptor binding affinity, ease of preparation, and expected rapid pharmacokinetics.

Efficient Kg-Scale Synthesis of Thrombin Inhibitor CRC 220

Jendralla, Heiner,Seuring, Bernhard,Herchen, Joerg,Kulitzscher, Bernd,Wunner, Joachim,et al.

, p. 12047 - 12068 (2007/10/02)

Potent thrombin inhibitor 2 is prepared in 10 steps with 20percent overall yield from commercial 4 on a kg-scale by the convergent approach depicted in Schemes 1 and 2.The (R)-configuration of the 4-amidinophenylalanine piperidide moiety is controlled by asymmetric hydrogenation.A novel method, the hydrogenolysis of amidoximes 11 and 21, is employed to attain a particularly clean transformation of the cyano into the amidinium functionality.Despite of the amorphous nature of target compound 2, the approach is devoid of any chromatographic purification.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 193270-06-3